After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Biolife Solutions Inc (BLFS) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.52, or 4.57%, to $11.91. The Biolife Solutions Inc has recorded 3,185 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that BioLife Solutions Reports Third Quarter 2023 Financial Results.
BLFS belongs to the Healthcare sector of the NASDAQ while operating in the Medical Instruments & Supplies industry. At the end of the last regular session, the stock closed at $11.39 and fluctuated between $12.12 as its day high and $11.33 as its day low. The current market capitalization of Biolife Solutions Inc is $495.35M. A total of 0.72 million shares were traded on the day, compared to an average of 540.60K shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, BLFS has seen 15 BUY and 20 SELL insider trades, representing the acquisition of 8,259 and the disposition of 8,147 shares. Over the last 12 months, there were 62 BUYs and 140 SELLs from insiders. Insiders purchased 688,400 shares during that period but sold 354,119.
In the most recent transaction, Rice Michael sold 72,603 shares of BLFS for 9.13 per share on Oct 30. After the transaction, the Former CEO and Director now owns 347,085 company shares. In a previous transaction on Oct 19, Casdin Partners Master Fund, L bought 927,165 shares at 11.19 per share. BLFS shares that 10% Owner owns now total 8,557,165.
Among the insiders who sold shares, Rice Michael disposed of 831 shares on Sep 28 at a per-share price of $14.16. This resulted in the Chief Executive Officer holding 418,635 shares of BLFS after the transaction. In another insider transaction, Mathew Aby J. sold 659 shares at $14.16 per share on Sep 28. Company shares held by the EVP & Chief Scientific Officer now total 273,121.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for BLFS in the last 3 months, the mean price target is $23.86 with high estimates of $30.00 and low estimates of $18.00. In terms of 52-week highs and lows, BLFS has a high of $26.89 and a low of $8.92.
As of this writing, BLFS has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.33 per share and a lower estimate of -$0.41. The company reported an EPS of -$0.32 in the last quarter, which was -52.40% lower than expectations of -$0.21.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BLFS’s latest balance sheet shows that the firm has $69.87M in Cash & Short Term Investments as of fiscal 2021. There were $26.88M in debt and $39.97M in liabilities at the time. Its Book Value Per Share was $8.11, while its Total Shareholder’s Equity was $480.75M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BLFS is Buy with a score of 5.00.